FDA Adverse Event Malfunction Summary report: N

ACCESS VITAMIN B12

MDR report key: 4376635 · Received January 1, 2015

Report

Report Number
2122870-2015-00001
Event Type
Malfunction
Date Received
January 1, 2015
Date of Event
December 2, 2014
Report Date
December 2, 2014
Manufacturer
BECKMAN COULTER
Product Code
CDD
PMA / PMN Number
K140496
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER DID NOT PROVIDE THE PATIENT'S WEIGHT. THERE IS NO INDICATION THAT THE ACCESS VITAMIN B12 REAGENT USED BY THE CUSTOMER WAS RETURNED FOR EVALUATION. BECKMAN COULTER ANALYSIS OF THE PATIENT SAMPLE INDICATED EVIDENCE OF ALKALINE PHOSPHATASE (ALP) INTERFERENCE, AS VITAMIN B12 WAS REDUCED BY 74% WITH THE ADDITION OF ALP BLOCKER. THE INSTRUCTIONS FOR USE FOR ACCESS VITAMIN B12 DOES NOT INCLUDE A LIMITATION FOR ALP INTERFERENCE.

Description of Event or Problem · 1

THE CUSTOMER REPORTED OBTAINING AN ERRONEOUS VITAMIN B12 RESULT FOR ONE PATIENT SAMPLE ON THE LABORATORY'S UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM (SERIAL NUMBER (B)(4)). THE INITIAL RESULT OBTAINED WAS >1500 PG/ML, WHICH WAS REPORTED OUT OF THE LABORATORY. THE PATIENT WAS EXPECTED TO BE WITHIN THE NORMAL REFERENCE RANGE FOR VITAMIN B12. THE SAMPLE WAS DILUTED 1:5 AND RE-ANALYZED ON THE SAME INSTRUMENT, WHICH YIELDED 453 PG/ML, WHICH WAS IN THE NORMAL REFERENCE RANGE. THERE IS NO REPORT OF PATIENT INJURY OR CHANGE TO PATIENT TREATMENT IN CONNECTION WITH THIS EVENT. THE SAMPLE WAS CENTRIFUGED AT 3000 RPM FOR 8 MINUTES. SYSTEM CHECK PASSED ON (B)(4) 2014. THE CUSTOMER SENT THE PATIENT SAMPLE TO BECKMAN COULTER FOR SAMPLE INTERFERENCE TESTING. REFERENCE RANGE FOR ACCESS VITAMIN B12: 180 - 914 PG/ML.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
187 ACCESS VITAMIN B12 RADIOASSAY, VITAMIN B12 CDD BECKMAN COULTER NA 430162

Patients

Seq Age Sex Outcome Treatment
1 73 YR